Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Eap

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Therapeutic Drug Monitoring|July 2, 2004
Therapeutic monitoring of antidepressants in the era of pharmacogenetics studiesC B Eap, E Jaquenoud Sirot, P Baumann
The Journal of Nervous and Mental Disease|January 5, 2002
Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerationsP Baumann, C B Eap, D F Zullino
The American Journal of Psychiatry|April 3, 2001
Ondansetron for tardive dyskinesiaD F Zullino, C B Eap, P Voirol
Human Genetics|December 1, 1989
Use of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variantsL Tomei, C B Eap, P Baumann, et al.
Therapeutic Drug Monitoring|October 1, 1996
Fluoxetine addition to methadone in addicts: pharmacokinetic aspectsG Bertschy, C B Eap, K Powell, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatographyM Kosel, C B Eap, M Amey, et al.
Therapeutic Drug Monitoring|February 1, 1994
Probable metabolic interaction between methadone and fluvoxamine in addict patientsG Bertschy, P Baumann, C B Eap, et al.
Pharmacopsychiatry|April 30, 1998
Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotypingP Baumann, F Broly, M Kosel, et al.
Pharmacopsychiatry|April 5, 2012
Adherence to antidepressant treatment: what the doctor thinks and what the patient saysN Loayza, S Crettol, F Riquier, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 25, 2010
Lack of association between genetic polymorphisms of ARRB2 and alcohol dependence in a Caucasian populationB Oneda, M Preisig, M Dobrinas, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Therapeutic Drug Monitoring|July 2, 2004
Therapeutic monitoring of antidepressants in the era of pharmacogenetics studiesC B Eap, E Jaquenoud Sirot, P Baumann
The Journal of Nervous and Mental Disease|January 5, 2002
Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerationsP Baumann, C B Eap, D F Zullino
The American Journal of Psychiatry|April 3, 2001
Ondansetron for tardive dyskinesiaD F Zullino, C B Eap, P Voirol
Human Genetics|December 1, 1989
Use of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variantsL Tomei, C B Eap, P Baumann, et al.
Therapeutic Drug Monitoring|October 1, 1996
Fluoxetine addition to methadone in addicts: pharmacokinetic aspectsG Bertschy, C B Eap, K Powell, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 30, 1998
Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatographyM Kosel, C B Eap, M Amey, et al.
Therapeutic Drug Monitoring|February 1, 1994
Probable metabolic interaction between methadone and fluvoxamine in addict patientsG Bertschy, P Baumann, C B Eap, et al.
Pharmacopsychiatry|April 30, 1998
Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotypingP Baumann, F Broly, M Kosel, et al.
Pharmacopsychiatry|April 5, 2012
Adherence to antidepressant treatment: what the doctor thinks and what the patient saysN Loayza, S Crettol, F Riquier, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 25, 2010
Lack of association between genetic polymorphisms of ARRB2 and alcohol dependence in a Caucasian populationB Oneda, M Preisig, M Dobrinas, et al.
Pageof 10